The widespread use of genome-wide diagnostic screening methods has
greatly increased the frequency with which incidental (but possibly pathogenic)
copy number changes affecting single genes are detected. These findings require
validation to allow appropriate clinical management. Deletion variants can
usually be readily validated using a range of short-read next-generation
sequencing strategies, but the characterization of duplication variants at
nucleotide resolution remains challenging. This presents diagnostic problems,
since pathogenicity cannot generally be assessed without knowing the structure
of the variant. We have used a novel Cas9 enrichment strategy, in combination
with long-read single-molecule nanopore sequencing, to address this need. We
describe the nucleotide-level resolution of two problematic cases, both of whom
presented with neurodevelopmental problems and were initially investigated by
array CGH. In the first case, an incidental 1.7-kb imbalance involving a partial
duplication of VHL exon 3 was detected. This variant was
inherited from the patient’s father, who had a history of renal cancer at
38 years. In the second case, an incidental ~200-kb de
novo duplication that included DMD exons 30-44 was
resolved. In both cases, the long-read data yielded sufficient information to
enable Sanger sequencing to define the rearrangement breakpoints, and creation
of breakpoint-spanning PCR assays suitable for testing of relatives. Our Cas9
enrichment and nanopore sequencing approach can be readily adopted by molecular
diagnostic laboratories for cost-effective and rapid characterization of
challenging duplication-containing alleles. We also anticipate that in future
this method may prove useful for characterizing acquired translocations in
tumour cells, and for precisely identifying transgene integration sites in mouse
models.